Sarcopenic obesity and skeletal development in children: recent advances
-
By
-
Yumo Liu
-
Xinyu Li
-
Xuhan Liu
-
July 13, 2026
Clinical Scorecard: Recent Insights into Sarcopenic Obesity and Bone Development in Pediatric Populations
At a Glance
| Category | Detail |
|---|
| Condition | Sarcopenic Obesity in Children |
| Key Mechanisms | Excess adiposity and diminished muscle mass negatively influence physical development and skeletal health. |
| Target Population | Pediatric populations, particularly children and adolescents. |
| Care Setting | Clinical practice focusing on childhood obesity and its impact on bone health. |
Key Highlights
- Sarcopenic obesity (SO) is characterized by the coexistence of excessive adiposity and reduced muscle mass.
- SO may impair bone formation through mechanical loading alterations and endocrine dysregulation.
- The absence of standardized definitions and diagnostic criteria for pediatric SO poses challenges for research and clinical practice.
- Children with obesity often present with impaired bone development and decreased bone density.
- Timely prevention and intervention are crucial during critical developmental stages.
Guideline-Based Recommendations
Diagnosis
- Current definitions of SO in children rely on body composition parameters and functional measures.
Management
- Lifestyle-based interventions are recommended for the prevention and management of SO.
Monitoring & Follow-up
- Regular assessment of muscle mass and function is important for identifying children at risk of SO.
Risks
- Inadequate bone accumulation during peak bone mass acquisition can lead to long-term skeletal issues.
Patient & Prescribing Data
Children and adolescents with obesity.
Focus on lifestyle modifications to address both adiposity and muscle mass.
Clinical Best Practices
- Incorporate functional measures like handgrip strength in the assessment of SO.
- Utilize imaging techniques for accurate evaluation of muscle mass.
Related Resources & Content
